Yuhan Corporation
Research Yuhan Corporation (000100.KS) on Bullrun: market cap KRW 6.01T, dividend yield 0.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker000100.KS
- ExchangeKS
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 6.01T
- Dividend yield0.8%
- Financial periodQ2 2026
- RevenueKRW 639.45B
- Net incomeKRW 70.32B
- Free cash flow-KRW 19.18B
- Gross margin35.6%
Valuation Snapshot
latest market cap is KRW 6.01T; dividend yield is 0.8%.
Peer valuation comparison
Latest dividend yield is 0.75% versus a Healthcare sector median of 2.4% (68.8% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 6.01T | n/a | 0.8% | 600 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 600 KRW, yield 0.8%.
About Yuhan Corporation
Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and analytical method development and regulatory support.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Yuhan Corporation's market cap?
Yuhan Corporation's market capitalization is KRW 6.01T.
Does Yuhan Corporation pay a dividend?
Yuhan Corporation has a dividend yield of 0.8%.
What does Yuhan Corporation do?
Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and analytical method development and regulatory support.